OpenVSafe by OpenVAERS
Search V-safe

BL2-14427-12389

2 vaccinations 5 coded responses 18 check-ins 5 free-text entries 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
626 / IL
Registered
2021-11-18
Relationship
Child or adolescent in my care
Guardian
BRP-11373-74521
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-18
    Registered in v-safe
  2. 2021-11-24
    Dose 1 — Pfizer-BioNTech
  3. 2021-11-26
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2021-11-28
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  5. 2021-11-29
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-01
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-12-08
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  8. 2021-12-16
    Health check-in — day 21, dose 1, dependent
    Feeling: Good
    Adult check-in
  9. 2021-12-19
    Dose 2 — Pfizer-BioNTech
  10. 2021-12-20
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: No appetite
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-12-21
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain · None
    Adult check-in
  12. 2021-12-22
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Rhinorrhoea — Feeling: Fair
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-12-23
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Rhinorrhoea — Feeling: Fair · Chills
    Free text: Running nose
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-12-24
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Nasal congestion — Feeling: Fair
    Free text: Stuffy nose
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-12-26
    Survey response — day 7, dose 2, dependent
    MedDRA: Nasal congestion — Feeling: Fair
    Free text: Stuffy nose
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-01-04
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  17. 2022-01-09
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  18. 2022-01-16
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  19. 2022-01-23
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  20. 2022-01-30
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  21. 2022-03-22

Vaccinations

DoseDateManufacturerCo-administered
12021-11-24Pfizer-BioNTech No
22021-12-19Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 2, dependent

2021-12-20

Systemic reaction (other): No appetite

2021-12-22

Systemic reaction (other): Runny nose

2021-12-23

Systemic reaction (other): Running nose

2021-12-24

Systemic reaction (other): Stuffy nose

Release 10 — day 7, dose 2, dependent

2021-12-26

Systemic reaction (other): Stuffy nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRODecreased appetite · · ✓
SRONasal congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release